Elanco Animal Health Inc Quarterly Amortization of Intangible Assets in USD from Q3 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Elanco Animal Health Inc quarterly/annual Amortization of Intangible Assets history and growth rate from Q3 2017 to Q2 2024.
  • Elanco Animal Health Inc Amortization of Intangible Assets for the quarter ending June 30, 2024 was $131M, a 3.68% decline year-over-year.
  • Elanco Animal Health Inc Amortization of Intangible Assets for the twelve months ending June 30, 2024 was $542M, a 2.65% increase year-over-year.
  • Elanco Animal Health Inc annual Amortization of Intangible Assets for 2023 was $548M, a 3.79% increase from 2022.
  • Elanco Animal Health Inc annual Amortization of Intangible Assets for 2022 was $528M, a 5.04% decline from 2021.
  • Elanco Animal Health Inc annual Amortization of Intangible Assets for 2021 was $556M, a 54.4% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $542M $131M -$5M -3.68% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $547M $133M -$1M -0.75% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $548M $138M +$8M +6.15% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $540M $140M +$12M +9.38% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $528M $136M +$3M +2.26% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $525M $134M -$3M -2.19% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $528M $130M -$9M -6.48% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $537M $128M -$13M -9.22% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $550M $133M +$4M +3.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $546M $137M -$10M -6.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $556M $139M -$24M -14.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $580M $141M +$45M +46.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $535M $129M +$80M +163% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $455M $147M +$95M +183% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $360M $163M +$112M +220% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $248M $96M +$45.3M +89.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $203M $49M -$300K -0.61% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $203M $52M +$3M +6.12% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $200M $51M +$900K +1.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $199M $50.7M +$2M +4.11% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $197M $49.3M -$100K -0.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $197M $49M -$200K -0.41% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $197M $50.1M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $48.7M -$2.9M -5.62% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $49.4M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $49.2M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q3 2017 $51.6M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.